Regulatory Rollback: CFPB’s Withdrawal of Informal Guidance Sparks New Litigation Dynamics – The Consumer Finance Podcast
Top challenges with Compliance Management
The Capital Ratio Podcast | Entering the US Banking Market
2023 CRA Rule Repeal: Lessons to be Learned
Unlocking Crypto's Future: Insights From Coinbase's John D'Agostino — The Crypto Exchange Podcast
Point-of-Sale Finance Series: The Great Debate of Loans vs. Credit Sales — The Consumer Finance Podcast
Importance of Compliance Management in times of transition
The fatal flaws in the 2023 CRA rule
Navigating the Future of Payment Stablecoins: Legislative Updates and Market Implications — Payments Pros – The Payments Law Podcast
Navigating the Future of Payment Stablecoins: Legislative Updates and Market Implications — The Crypto Exchange Podcast
CHPS Podcast Episode 2: Bitcoin in the Halls of Power
Predictions regarding the 2023 CRA Rule and Section 1071 and how to prepare for expected developments
Regulatory Ramblings: Episode 66 – The U.S. Strategic Reserve and the Emerging Multipolar Crypto World + Recent Developments in US Virtual Asset Regulation with Henri Arslanian and Andrew Fei
New York's Bold Move to Create a Mini CFPB — The Consumer Finance Podcast
The Capital Ratio Podcast | Stablecoins: Regulatory Issues for UK and EU Banks To Consider
Through the Crystal Ball: What's Next for Auto Finance — Moving the Metal: The Auto Finance Podcast
Consumer Finance Monitor Podcast Episode: How to Use the Restatement of Consumer Contracts - A Guide for Judges
2024 in Review: Major Debt Collection Trends and 2025 Outlook — The Consumer Finance Podcast
Fintech Focus Podcast | Crypto 2.0: What’s Next in the US?
State Regulators Step Up: Responding to the CFPB's New Leadership — Regulatory Oversight Podcast
On June 12, 2025, the Securities and Exchange Commission issued a release announcing that it was withdrawing 14 notices of proposed rulemaking issued between March 2022 and November 2023 and stating that it “does not intend...more
So . . . . Nice, quiet week while we were gone, right? Wall Street forecasts are always dicey, but it sure looks like Pfizer’s solid vaccine news (along with this weekend’s newfound presidential certainty) could make for...more